Highstreet Asset Management’s Biogen BIIB Stock Holding History

Highstreet Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$607K	Sell	2,047 -1,775	-46%	-$492K	0.03%	214
2019 Q3	$890K	Sell	3,822 -20	-0.5%	-$4.66K	0.04%	144
2019 Q2	$899K	Sell	3,842 -2,070	-35%	-$478K	0.04%	156
2019 Q1	$1.4M	Sell	5,912 -1,312	-18%	-$413K	0.08%	108
2018 Q4	$2.17M	Buy	7,224 +240	+3%	+$76.6K	0.14%	83
2018 Q3	$2.47M	Sell	6,984 -1,022	-13%	-$352K	0.14%	84
2018 Q2	$2.32M	Buy	8,006 +4,852	+154%	+$1.36M	0.14%	77
2018 Q1	$864K	Buy	+3,154	New	+$979K	0.06%	143
2017 Q2	–	Sell	-2,783	Closed	-$761K	–	291
2017 Q1	$761K	Buy	+2,783	New	+$787K	0.25%	106

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Highstreet Asset Management's BIIB Position: Q4 2019 in Review

Highstreet Asset Management reduced its Biogen (BIIB) stake by 46% in Q4 2019, selling an estimated $492K and leaving 2,047 shares worth $607K. The position accounts for 0.03% of the portfolio, ranked #214.

Highstreet Asset Management first reported a position in BIIB in Q1 2017 and has held it in 9 quarters since. The position peaked at $2.47M in Q3 2018. 1,103 funds tracked by Wall St. Rank hold BIIB as of Q4 2019.

Highstreet Asset Management held 2,047 shares of Biogen worth $607K as of Q4 2019.
Highstreet Asset Management sold 1,775 Biogen shares in Q4 2019, an estimated $492K.
Biogen made up 0.03% of Highstreet Asset Management's portfolio in Q4 2019, its #214 holding.
Highstreet Asset Management first reported a position in Biogen in Q1 2017 and has held it in 9 quarters since.
Highstreet Asset Management's Biogen position peaked at $2.47M in Q3 2018.
1,103 funds tracked by Wall St. Rank held Biogen as of Q4 2019.

Based on Highstreet Asset Management's 13F filing for Q4 2019, filed 12 Feb 2020.